Aoife O’Farrell

Statistics

Publications

Citations

294

H-Index

Active since

2020

Affiliations

University of Pennsylvania(Current)

Massachusetts Institute of Technology

University of California San Diego

UC San Diego Health System

Aoife O’Farrell is an author at University of Pennsylvania specializing in checkpoint inhibitor therapy, molecular biology, and immune checkpoint inhibitors.

ORCID

Publications per year

2020–2024

Publications

Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC

Robert Saddawi‐Konefka, Aoife O’Farrell, Farhoud Faraji et al. · Nature Communications · 2022 · 174 citations · Full text

Life Sciences, Immunology, Oncology +17

Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer

Zhiyong Wang, Yusuke Goto, Michael M. Allevato et al. · Nature Communications · 2021 · 85 citations · Full text

Medicine, Cancer Biology, Oncology +15

Post-transcriptional splicing can occur in a slow-moving zone around the gene

Allison Coté, Aoife O’Farrell, Ian Dardani et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 21 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

AP-1 Mediates Cellular Adaptation and Memory Formation During Therapy Resistance

Jingxin Li, Pavithran T. Ravindran, Aoife O’Farrell et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2024 · 14 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

1–4 of 4